| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.00B | 86.46B | 94.92B | 84.00B | 89.16B | 89.82B |
| Gross Profit | 12.92B | 12.73B | 14.10B | 12.72B | 12.97B | 8.59B |
| EBITDA | 6.20B | 6.06B | 7.79B | 6.96B | 7.51B | 3.55B |
| Net Income | 3.76B | 3.69B | 5.09B | 5.44B | 4.74B | 1.81B |
Balance Sheet | ||||||
| Total Assets | 83.00B | 92.41B | 91.09B | 88.58B | 81.64B | 91.59B |
| Cash, Cash Equivalents and Short-Term Investments | 14.01B | 13.22B | 18.89B | 27.32B | 16.40B | 14.38B |
| Total Debt | 3.31B | 12.70B | 4.43B | 4.43B | 6.28B | 18.21B |
| Total Liabilities | 34.53B | 42.54B | 43.70B | 45.88B | 43.28B | 57.74B |
| Stockholders Equity | 46.93B | 48.32B | 45.93B | 41.32B | 37.09B | 32.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -11.35B | -5.50B | 14.17B | 14.67B | -6.00B |
| Operating Cash Flow | 0.00 | -10.26B | -4.03B | 15.07B | 15.95B | -5.45B |
| Investing Cash Flow | 0.00 | -1.85B | -3.61B | -1.33B | -1.48B | -651.00M |
| Financing Cash Flow | 0.00 | 6.45B | -1.31B | -2.90B | -12.66B | 5.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥51.37B | 6.41 | ― | 3.97% | 2.85% | 317.62% | |
75 Outperform | ¥52.34B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
67 Neutral | ¥70.48B | 11.22 | ― | 2.56% | 1.71% | 14.20% | |
65 Neutral | ¥55.09B | 9.11 | ― | 2.84% | 15.45% | 43.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥72.17B | 7.46 | ― | 3.84% | -8.79% | ― | |
60 Neutral | ¥63.74B | 19.35 | ― | 1.57% | 11.01% | 231.83% |